Snekkersten, Denmark

Thomas Franch

USPTO Granted Patents = 25 

 

Average Co-Inventor Count = 6.9

ph-index = 8

Forward Citations = 224(Granted Patents)


Location History:

  • Odense C, DK (2010 - 2015)
  • Odense, DK (2017 - 2020)
  • Copenhagen, DK (2008 - 2023)
  • Snekkersten, DK (2011 - 2023)

Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Thomas Franch**

Introduction

Thomas Franch is a prominent inventor based in Snekkersten, Denmark, with a remarkable portfolio of 24 patents to his name. His work focuses on innovative solutions in the field of pharmaceutical sciences and enzymatic synthesis, paving the way for new therapeutic approaches.

Latest Patents

Among his latest contributions to the field, Thomas has developed patents for "Compounds Active Towards Nuclear Receptors," which includes pharmaceutical compositions and therapeutic uses of these compounds. Additionally, he has worked on "Enzymatic Encoding Methods for Efficient Synthesis of Large Libraries," outlining a novel method for creating bifunctional complexes that enhance the efficiency of enzymatic reactions.

Career Highlights

Thomas has made significant strides in various research and development roles. He has contributed to the advancement of medicinal chemistry and biotechnology during his tenure at prominent institutions. Notably, he has worked with Nuevolution A/S and Neuvolution A/S, where he played a crucial role in several innovative projects.

Collaborations

Throughout his career, Thomas has collaborated with talented professionals, including Alex Haahr Gouliaev and Henrik Pedersen. These partnerships have helped him expand his research capabilities and explore new avenues for innovation.

Conclusion

With a solid foundation in patenting innovative technologies and compounds, Thomas Franch continues to contribute to the scientific community. His ongoing research not only holds promise for therapeutic advancements but also reflects his dedication to the field of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…